337 related articles for article (PubMed ID: 19769750)
1. Maternal human parvovirus B19 infection and the risk of fetal death and low birthweight: a case-control study within 35 940 pregnant women.
Sarfraz AA; Samuelsen SO; Bruu AL; Jenum PA; Eskild A
BJOG; 2009 Oct; 116(11):1492-8. PubMed ID: 19769750
[TBL] [Abstract][Full Text] [Related]
2. Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight.
Eskild A; Jenum PA; Bruu AL
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1035-41. PubMed ID: 16232169
[TBL] [Abstract][Full Text] [Related]
3. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
[TBL] [Abstract][Full Text] [Related]
4. Detection of parvovirus B19 infection in first and second trimester fetal loss.
de Krijger RR; van Elsacker-Niele AM; Mulder-Stapel A; Salimans MM; Dreef E; Weiland HT; van Krieken JH; Vermeij-Keers C
Pediatr Pathol Lab Med; 1998; 18(1):23-34. PubMed ID: 9566279
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection during pregnancy and the risk of adverse pregnancy outcome.
Eskild A; Bruu AL; Stray-Pedersen B; Jenum P
BJOG; 2005 Dec; 112(12):1620-4. PubMed ID: 16305564
[TBL] [Abstract][Full Text] [Related]
6. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases.
Enders M; Weidner A; Zoellner I; Searle K; Enders G
Prenat Diagn; 2004 Jul; 24(7):513-8. PubMed ID: 15300741
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study.
Lassen J; Jensen AK; Bager P; Pedersen CB; Panum I; Nørgaard-Pedersen B; Aaby P; Wohlfahrt J; Melbye M
Am J Epidemiol; 2012 Nov; 176(9):803-7. PubMed ID: 23051601
[TBL] [Abstract][Full Text] [Related]
8. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection.
Nyman M; Skjöldebrand-Sparre L; Broliden K
J Perinat Med; 2005; 33(2):176-8. PubMed ID: 15843271
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report].
Stenner S; Enders G; Klee A; Eiden U; Weidner A; Gonser M
Z Geburtshilfe Neonatol; 2002; 206(3):102-6. PubMed ID: 12098826
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
12. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran.
Ziyaeyan M; Rasouli M; Alborzi A
Jpn J Infect Dis; 2005 Apr; 58(2):95-7. PubMed ID: 15858287
[TBL] [Abstract][Full Text] [Related]
13. [Concentration of interleukin-6 and interleukin-12 in pregnant women infected and noninfected with parvovirus B19].
Friedek D; Romanik M; Rogala-Zawada D; Mercik R; Kłuciński P
Wiad Lek; 2001; 54(9-10):492-7. PubMed ID: 11816291
[TBL] [Abstract][Full Text] [Related]
14. Maternal-fetal transmission of human parvovirus B19 genotype 3.
Candotti D; Danso K; Parsyan A; Dompreh A; Allain JP
J Infect Dis; 2006 Sep; 194(5):608-11. PubMed ID: 16897659
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection.
Enders M; Helbig S; Hunjet A; Pfister H; Reichhuber C; Motz M
J Virol Methods; 2007 Dec; 146(1-2):409-13. PubMed ID: 17854916
[TBL] [Abstract][Full Text] [Related]
16. Parvovirus B19 infection in pregnancy studied by maternal viral load and immune responses.
de Haan TR; Beersma MF; Claas EC; Oepkes D; Kroes AC; Walther FJ
Fetal Diagn Ther; 2007; 22(1):55-62. PubMed ID: 17003557
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
Vega J; Sáez G; Smith M; Agurto M; Morris NM
Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between maternal infection with human parvovirus B19 and fetal death and congenital malformation].
Li B; Qu X; Wang S
Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):24-6. PubMed ID: 11778539
[TBL] [Abstract][Full Text] [Related]
20. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings.
Syridou G; Spanakis N; Konstantinidou A; Piperaki ET; Kafetzis D; Patsouris E; Antsaklis A; Tsakris A
J Med Virol; 2008 Oct; 80(10):1776-82. PubMed ID: 18712818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
